Amanote Research
Register
Sign In
Synergistic Antitumor Effects of Berbamine and Paclitaxel Through ROS/Akt Pathway in Glioma Cells
Evidence-based Complementary and Alternative Medicine
- Egypt
doi 10.1155/2017/8152526
Full Text
Open PDF
Abstract
Available in
full text
Categories
Alternative Medicine
Complementary
Date
January 1, 2017
Authors
Feng Jia
Shu Ruan
Ning Liu
Linshan Fu
Publisher
Hindawi Limited
Related search
Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel in Vitro and in Vivo
PLoS ONE
Multidisciplinary
The Isoprenoid Derivative N6 -Benzyladenosine CM223 Exerts Antitumor Effects in Glioma Patient-Derived Primary Cells Through the Mevalonate Pathway
British Journal of Pharmacology
Pharmacology
Berbamine Exhibits Potent Antitumor Effects on Imatinib-Resistant CML Cells in Vitro and in Vivo
Acta Pharmacologica Sinica
Medicine
Pharmacology
Synergistic Effects of Phenylhexyl Isothiocyanate and LY294002 on the PI3K/Akt Signaling Pathway in HL‑60 Cells
Oncology Letters
Cancer Research
Oncology
Cordycepin Induces Apoptosis in Human Bladder Cancer T24 Cells Through ROS-dependent Inhibition of the PI3K/Akt Signaling Pathway
BioScience Trends
Biochemistry
Health
Medicine
Genetics
Molecular Biology
MicroRNA miR-451 Downregulates the PI3K/AKT Pathway Through CAB39 in Human Glioma
International Journal of Oncology
Cancer Research
Oncology
Synergistic Antitumor Effects of Combined Deguelin and Cisplatin Treatment in Gastric Cancer Cells
Oncology Letters
Cancer Research
Oncology
miR-221/222 Promote Malignant Progression of Glioma Through Activation of the Akt Pathway
International Journal of Oncology
Cancer Research
Oncology
Paclitaxel Resistance in McF-7/PTX Cells Is Reversed by Paeonol Through Suppression of the SET/phosphatidylinositol 3-Kinase/Akt Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine